Switch to
| Predicate | Object |
|---|---|
| rdf:type | |
| lifeskim:mentions | |
| pubmed:dateCreated |
1973-12-14
|
| pubmed:language |
eng
|
| pubmed:journal | |
| pubmed:citationSubset |
AIM
|
| pubmed:chemical | |
| pubmed:status |
MEDLINE
|
| pubmed:month |
Oct
|
| pubmed:issn |
0022-1899
|
| pubmed:author | |
| pubmed:issnType |
Print
|
| pubmed:volume |
128
|
| pubmed:owner |
NLM
|
| pubmed:authorsComplete |
Y
|
| pubmed:pagination |
Suppl:S354-7
|
| pubmed:dateRevised |
2004-11-17
|
| pubmed:meshHeading |
pubmed-meshheading:4744017-Cephalosporins,
pubmed-meshheading:4744017-Half-Life,
pubmed-meshheading:4744017-Humans,
pubmed-meshheading:4744017-Kidney,
pubmed-meshheading:4744017-Kidney Diseases,
pubmed-meshheading:4744017-Peritoneal Dialysis,
pubmed-meshheading:4744017-Renal Dialysis,
pubmed-meshheading:4744017-Sulfides,
pubmed-meshheading:4744017-Tetrazoles,
pubmed-meshheading:4744017-Thiadiazoles
|
| pubmed:year |
1973
|
| pubmed:articleTitle |
Pharmacology of cefazolin in patients with normal and abnormal renal function.
|
| pubmed:publicationType |
Journal Article
|